Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population

AIDS Patient Care and STDs

Volumn 23, Issue 11, 2009, Pages 925-929

  Scott, John D ^a   Wald, Anna ^a,b   Kitahata, Mari ^a   Krantz, Elizabeth ^a   Drolette, Linda ^a   Corey, Lawrence ^a,b,c   Wang, Chia C ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RACE DIFFERENCE; RETROSPECTIVE STUDY; SUBSTANCE ABUSE; SURVIVAL RATE; TREATMENT OUTCOME; URBAN POPULATION; VIRUS HEPATITIS; VIRUS LOAD; WESTERN BLOTTING;

ADULT; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 72849123569     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2009.0099     Document Type: Article

References (14)

1. Staples C Jr, Rimland D, Dudas D. Hepatitis C in the HIV Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): The effect of coinfection on survival. Clin Infect Dis 1999;29:150-154.
2. Tedaldi EM, Baker RK, Moorman AC, et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2003;36:363-367.
3. Carrat F, Bani-Sadr F, Pol S, et al. Pegylated inteferon alfa-2b vs standard interferon alfa-2b, plus ribavirin for chronic hepatitis C in HIV-infected patients. JAMA 2004;292:2839-2848.
4. Chung RT, Andersen J, Volberding P, et al. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004;351:451-459.
5. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004;351:438-450.
6. Fultz SL, Justice AC, Butt AA, Rabenack L, Weissman R, Rodriguez-Barradas M. Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection. Clin Infect Dis 2003;36:1039-1046.
7. Mehta SH, Lucas GM, Mirel LB, et al. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS 2006;20:2361-2369.
8. Yehia BR, Gebo KA, Hicks PB, et al. Structures of care in the clinics of the HIV Research Network. AIDS Patient Care STDs 2008;22:1007-1013.
9. Crane HM, Van Rompaey SE, Kitahata MM. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS 2006;20:1019-1026.
10. Fried MW, Shiffman ML, Reddy R, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982.
11. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001;358:958-965.
12. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999;30: 1054-1058. (Pubitemid 29458296)
13. Ulett KB, Willig JH, Lin H-Y, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDs 2009;23:41-49.
14. Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med 2004;19:357-365.